Ela Markovsky

853 total citations
15 papers, 696 citations indexed

About

Ela Markovsky is a scholar working on Oncology, Molecular Biology and Biomaterials. According to data from OpenAlex, Ela Markovsky has authored 15 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 3 papers in Biomaterials. Recurrent topics in Ela Markovsky's work include Nanoparticle-Based Drug Delivery (3 papers), Bone health and treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Ela Markovsky is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), Bone health and treatments (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Ela Markovsky collaborates with scholars based in Israel, United States and Germany. Ela Markovsky's co-authors include Ronit Satchi‐Fainaro, Hemda Baabur‐Cohen, Galia Tiram, Anat Eldar‐Boock, Anna Scomparin, Dina Polyak, Shiran Ferber, Paula Ofek, Nickolay Koroukhov and Gershon Golomb and has published in prestigious journals such as Journal of Controlled Release, International Journal of Radiation Oncology*Biology*Physics and Oncotarget.

In The Last Decade

Ela Markovsky

15 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ela Markovsky Israel	11	298	268	179	115	78	15	696
Margit M. Janát‐Amsbury United States	16	202 0.7×	365 1.4×	138 0.8×	184 1.6×	74 0.9×	34	856
Dina Polyak Israel	11	313 1.1×	300 1.1×	216 1.2×	130 1.1×	65 0.8×	21	681
Taryn R. Bagby United States	8	231 0.8×	206 0.8×	165 0.9×	138 1.2×	150 1.9×	8	670
Allison N. Schorzman United States	14	250 0.8×	236 0.9×	213 1.2×	181 1.6×	59 0.8×	24	772
Yaohua Wei China	18	405 1.4×	326 1.2×	351 2.0×	76 0.7×	42 0.5×	32	851
Laura Pandolfi Italy	17	408 1.4×	353 1.3×	284 1.6×	102 0.9×	113 1.4×	42	990
Milan Paul India	17	281 0.9×	249 0.9×	320 1.8×	140 1.2×	45 0.6×	49	753
Yasmine Amitay Israel	13	382 1.3×	309 1.2×	230 1.3×	133 1.2×	35 0.4×	17	644
Arthur Rekechenetskiy United States	7	444 1.5×	335 1.3×	342 1.9×	158 1.4×	35 0.4×	7	842
Kyle Wagner United States	14	258 0.9×	204 0.8×	229 1.3×	111 1.0×	42 0.5×	28	652

Countries citing papers authored by Ela Markovsky

Since Specialization

Citations

This map shows the geographic impact of Ela Markovsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ela Markovsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ela Markovsky more than expected).

Fields of papers citing papers by Ela Markovsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ela Markovsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ela Markovsky. The network helps show where Ela Markovsky may publish in the future.

Co-authorship network of co-authors of Ela Markovsky

This figure shows the co-authorship network connecting the top 25 collaborators of Ela Markovsky. A scholar is included among the top collaborators of Ela Markovsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ela Markovsky. Ela Markovsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Vax, Einav, Rachel Shukrun, Naomi Pode‐Shakked, et al.. (2025). A novel Frizzled 7 antibody disrupts the Wnt pathway and inhibits Wilms tumor growth. Frontiers in Bioengineering and Biotechnology. 13. 1641137–1641137. 1 indexed citations

Wortel, Ruud C., Aviram Mizrachi, Ela Markovsky, et al.. (2019). Sildenafil Protects Endothelial Cells From Radiation-Induced Oxidative Stress. The Journal of Sexual Medicine. 16(11). 1721–1733. 24 indexed citations

Markovsky, Ela, et al.. (2018). PEGylated dendritic polyglycerol conjugate targeting NCAM-expressing neuroblastoma: Limitations and challenges. Nanomedicine Nanotechnology Biology and Medicine. 14(4). 1169–1179. 12 indexed citations

Markovsky, Ela, Sadna Budhu, Robert Samstein, et al.. (2018). An Antitumor Immune Response Is Evoked by Partial-Volume Single-Dose Radiation in 2 Murine Models. International Journal of Radiation Oncology*Biology*Physics. 103(3). 697–708. 67 indexed citations

Markovsky, Ela, et al.. (2018). Phosphorylation state of Ser165 in α-tubulin is a toggle switch that controls proliferating human breast tumors. Cellular Signalling. 52. 74–82. 7 indexed citations

Li, Hongyan, Ela Markovsky, Elisa de Stanchina, et al.. (2018). Pazopanib radio-sensitization of human sarcoma tumors. Oncotarget. 9(10). 9311–9324. 4 indexed citations

Markovsky, Ela, Anat Eldar‐Boock, Dikla Ben‐Shushan, et al.. (2017). Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine. Journal of Controlled Release. 249. 162–172. 20 indexed citations

Samstein, Robert, Ela Markovsky, James Russell, et al.. (2017). Partial Tumor Irradiation in a Murine Model is Sufficient for Tumor Control via Activation of an Antitumor Immune Response. International Journal of Radiation Oncology*Biology*Physics. 99(2). E616–E617. 2 indexed citations

Markovsky, Ela, Einav Vax, Dikla Ben‐Shushan, et al.. (2017). Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine. Molecular Cancer Therapeutics. 16(11). 2462–2472. 17 indexed citations

10.

Baabur‐Cohen, Hemda, Anat Eldar‐Boock, Eilam Yeini, et al.. (2016). In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio. Journal of Controlled Release. 257. 118–131. 53 indexed citations

11.

Markovsky, Ela, Hemda Baabur‐Cohen, & Ronit Satchi‐Fainaro. (2014). Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs. Journal of Controlled Release. 187. 145–157. 100 indexed citations

12.

Ben‐Shushan, Dikla, Ela Markovsky, Hadas Gibori, et al.. (2013). Overcoming obstacles in microRNA delivery towards improved cancer therapy. Drug Delivery and Translational Research. 4(1). 38–49. 53 indexed citations

13.

Markovsky, Ela, Hemda Baabur‐Cohen, Anat Eldar‐Boock, et al.. (2011). Administration, distribution, metabolism and elimination of polymer therapeutics. Journal of Controlled Release. 161(2). 446–460. 242 indexed citations

14.

Epstein-Barash, Hila, et al.. (2010). Physicochemical parameters affecting liposomal bisphosphonates bioactivity for restenosis therapy: Internalization, cell inhibition, activation of cytokines and complement, and mechanism of cell death. Journal of Controlled Release. 146(2). 182–195. 80 indexed citations

15.

Markovsky, Ela, Nickolay Koroukhov, & Gershon Golomb. (2007). Additive-Free Albumin Nanoparticles of Alendronate for Attenuating Inflammation Through Monocyte Inhibition. Nanomedicine. 2(4). 545–553. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact